Full Text View
Tabular View
No Study Results Posted
Related Studies
Epidural Analgesia Versus IV Meperidine for Labor Pain Control
This study has been completed.
Study NCT00296751   Information provided by Rambam Health Care Campus
First Received: February 24, 2006   Last Updated: April 18, 2008   History of Changes

February 24, 2006
April 18, 2008
March 2006
December 2006   (final data collection date for primary outcome measure)
Three lead ECG monitoring for 10 minutes will be performed 30 minutes after the administration.
Same as current
Complete list of historical versions of study NCT00296751 on ClinicalTrials.gov Archive Site
 
 
 
Epidural Analgesia Versus IV Meperidine for Labor Pain Control
Epidural Analgesia Versus IV Meperidine for Labor Pain Control. Objective Evaluation of the Pain Intensity Influence on the Autonomic Nervous System.

60 female that care for pain control during second stage of delivery, will choose between epidural or systemic analgesia. Continuous ECG (3 lead)monitoring will be recorded during the second stage for 10 minutes. 30 minutes after administration of either pain relief, a second recording of maternal ECG will take place for 10 minutes.

Population 60 female during second stage of delivery

  • Inclusion criteria : all parturients requiring pain relief will choose between systemic or epidural analgesia.
  • Exclusion Criteria: all parturients with cardiac disease, neurological disease, endocrine disease, diabetes, hypertension or any parturients being treated with medications that might effect the cardiovascular autonomic system.
  • Method: A 10 minute recording of a 3 lead ECG will be performed during the second stage of the delivery (3-7 CM opening).

the parturient will be lying on her left side for that period.

  • 30 minutes after administration of either epidural or systemic Meperidine for pain relief, a second recording of maternal ECG will take place for 10 minutes.
  • estimated duration of the procedure about one hour per woman.
 
Interventional
Other, Randomized, Open Label, Active Control, Parallel Assignment
Labor Pain
  • Procedure: ECG recording
  • Procedure: Epidural catheter insertion
  • Drug: Intravenous meperidine injection
  • Drug: Epidural Bupivacaine and fentanyl injection
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
60
December 2006
December 2006   (final data collection date for primary outcome measure)

Inclusion Criteria: all parturients requiring pain relief will choose between systemic or epidural analgesia.

Exclusion Criteria: all parturients with cardiac disease, neurological disease, endocrine disease, diabetes, hypertension or any parturients being treated with medications that might effect the cardiovascular or autonomic system.

-

Female
20 Years to 40 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT00296751
 
epiduralCTIL
Rambam Health Care Campus
 
Study Director: Amir Weissman, MD Rambam Health Care Campus
Principal Investigator: Olga Torchov, MD Rambam Health Care Campus
Rambam Health Care Campus
April 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP